These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 16823855)
1. NOS2A and the modulating effect of cigarette smoking in Parkinson's disease. Hancock DB; Martin ER; Fujiwara K; Stacy MA; Scott BL; Stajich JM; Jewett R; Li YJ; Hauser MA; Vance JM; Scott WK Ann Neurol; 2006 Sep; 60(3):366-73. PubMed ID: 16823855 [TBL] [Abstract][Full Text] [Related]
2. Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease. Hancock DB; Martin ER; Vance JM; Scott WK Neurogenetics; 2008 Oct; 9(4):249-62. PubMed ID: 18663495 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive association analysis of the NOS2A gene with Parkinson disease. Schulte C; Sharma M; Mueller JC; Lichtner P; Prestel J; Berg D; Gasser T Neurology; 2006 Dec; 67(11):2080-2. PubMed ID: 17159127 [TBL] [Abstract][Full Text] [Related]
4. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease. Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I Mov Disord; 2006 Dec; 21(12):2157-64. PubMed ID: 17078049 [TBL] [Abstract][Full Text] [Related]
5. Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians. Das G; Misra AK; Das SK; Ray K; Ray J Neurosci Lett; 2009 Aug; 460(1):16-20. PubMed ID: 19450659 [TBL] [Abstract][Full Text] [Related]
7. An investigation of NOS2A promoter polymorphisms in Australian multiple sclerosis patients. Bugeja MJ; Booth DR; Bennetts BH; Heard RN; Burgner D; Stewart GJ Eur J Hum Genet; 2005 Jul; 13(7):815-22. PubMed ID: 15856071 [TBL] [Abstract][Full Text] [Related]
8. alpha-Synuclein and Parkinson disease susceptibility. Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362 [TBL] [Abstract][Full Text] [Related]
9. Role of polymorphisms in dopamine synthesis and metabolism genes and association of DBH haplotypes with Parkinson's disease among North Indians. Punia S; Das M; Behari M; Mishra BK; Sahani AK; Govindappa ST; Jayaram S; Muthane UB; K TB; Juyal RC Pharmacogenet Genomics; 2010 Jul; 20(7):435-41. PubMed ID: 20498626 [TBL] [Abstract][Full Text] [Related]
11. Correlation of tau gene polymorphism with age at onset of Parkinson's disease. Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I Neurosci Lett; 2006 Sep; 405(3):202-6. PubMed ID: 16876320 [TBL] [Abstract][Full Text] [Related]
12. Toward identification of susceptibility genes for sporadic Parkinson's disease. Toda T; Momose Y; Murata M; Tamiya G; Yamamoto M; Hattori N; Inoko H J Neurol; 2003 Oct; 250 Suppl 3():III40-3. PubMed ID: 14579123 [TBL] [Abstract][Full Text] [Related]
13. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications. Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234 [TBL] [Abstract][Full Text] [Related]
14. Investigation of chromosome 17 candidate genes in susceptibility to TB in a South African population. Möller M; Nebel A; Valentonyte R; van Helden PD; Schreiber S; Hoal EG Tuberculosis (Edinb); 2009 Mar; 89(2):189-94. PubMed ID: 19147409 [TBL] [Abstract][Full Text] [Related]
15. Genetic association study of PINK1 coding polymorphisms in Parkinson's disease. Groen JL; Kawarai T; Toulina A; Rivoiro C; Salehi-Rad S; Sato C; Morgan A; Liang Y; Postuma RB; St George-Hyslop P; Lang AE; Rogaeva E Neurosci Lett; 2004 Dec; 372(3):226-9. PubMed ID: 15542245 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 20 gene and Parkinson's disease in the Japanese population. Satake W; Mizuta I; Suzuki S; Nakabayashi Y; Ito C; Watanabe M; Takeda A; Hasegawa K; Sakoda S; Yamamoto M; Hattori N; Murata M; Toda T Neuroreport; 2007 Jun; 18(9):937-40. PubMed ID: 17515805 [TBL] [Abstract][Full Text] [Related]
17. Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease. Deng Y; Newman B; Dunne MP; Silburn PA; Mellick GD Neurosci Lett; 2004 Aug; 366(3):326-31. PubMed ID: 15288444 [TBL] [Abstract][Full Text] [Related]
18. Tau haplotypes regulate transcription and are associated with Parkinson's disease. Kwok JB; Teber ET; Loy C; Hallupp M; Nicholson G; Mellick GD; Buchanan DD; Silburn PA; Schofield PR Ann Neurol; 2004 Mar; 55(3):329-34. PubMed ID: 14991810 [TBL] [Abstract][Full Text] [Related]
19. GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson's disease in a Japanese population. Kiyohara C; Miyake Y; Koyanagi M; Fujimoto T; Shirasawa S; Tanaka K; Fukushima W; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Miki T; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M; Parkinsonism Relat Disord; 2010 Aug; 16(7):447-52. PubMed ID: 20472488 [TBL] [Abstract][Full Text] [Related]
20. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Dickel DE; Veenstra-VanderWeele J; Cox NJ; Wu X; Fischer DJ; Van Etten-Lee M; Himle JA; Leventhal BL; Cook EH; Hanna GL Arch Gen Psychiatry; 2006 Jul; 63(7):778-85. PubMed ID: 16818867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]